The ACME Laboratories Ltd. (DSE:ACMELAB)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
75.30
-0.20 (-0.26%)
At close: Apr 28, 2026
3.01%
Market Cap 15.98B
Revenue (ttm) 38.86B
Net Income (ttm) 2.56B
Shares Out 211.60M
EPS (ttm) 12.11
PE Ratio 6.23
Forward PE n/a
Dividend 3.50 (4.64%)
Ex-Dividend Date Nov 19, 2025
Volume 158,334
Average Volume 204,501
Open n/a
Previous Close 75.50
Day's Range 75.00 - 75.80
52-Week Range 67.90 - 85.90
Beta 0.10
RSI 44.89
Earnings Date Apr 29, 2026

About The ACME Laboratories

The ACME Laboratories Ltd., a pharmaceutical company, engages in the manufacturing, marketing, and distribution of generic pharmaceutical formulation products in Bangladesh. The company offers pharmaceutical products in various therapeutic areas, such as allergic disorders, analgesic, antifribinolytic, anti-infective, antiviral, artificial sweeteners, cardiovascular, central nervous system (CNS), cough and cold, diabetes, eye care and preparations, gastroprokinetic, hepatobiliary, gastrointestinal, gynaecological, hand sanitizers, hormones and ... [Read more]

Industry Pharmaceutical Preparations
Founded 1954
Employees 9,025
Stock Exchange Dhaka Stock Exchange
Ticker Symbol ACMELAB
Full Company Profile

Financial Performance

In fiscal year 2025, The ACME Laboratories's revenue was 35.94 billion, an increase of 12.54% compared to the previous year's 31.93 billion. Earnings were 2.43 billion, a decrease of -1.12%.

Financial Statements

News

There is no news available yet.